...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Slide 6

Can't say I do.  Good question for IR.... one they can actually answer.

Share
New Message
Please login to post a reply